OHSU has seen a decrease in COVID-related hospitalizations, but urges the public to continue taking public health precautions to avoid another case surge.

In a story about when society could return to the way things were before the pandemic, Mark Slifka, Ph.D., says effective vaccination will help us get there.

Zane Horowitz, M.D., will present on the fungal genus Amanita at the annual scientific meeting of the American College of Medical Toxicology in April.

A story about Oregon House Bill 2980, which proposes funding short-term facilities called peer respite centers for those experiencing metal health crises notes Jonathan Betlinski, M.D., testified before about the centers, saying they can “result in significant positive outcomes for patients, and save health care dollars.”

Although the pandemic has increased student interest in nursing, Susan Bakewell-Sachs, Ph.D., R.N., says there are more applicants than available student slots at nursing schools.

Renee Edwards, M.D., M.B.A., notes OHA guidance places vaccination clinic volunteers in Oregon’s Phase 1A vaccination group and makes them eligible to be vaccinated.

Peter Graven, Ph.D., says Oregon could see another surge in COVID cases if more contagious variants take hold before the most vulnerable are vaccinated.

In a story discussing how vaccinations can help Oregon achieve herd immunity against the novel coronavirus, Mark Slifka, Ph.D., says “If you want to get 75% people vaccinated, you need to ask 80 or 90% of people to get vaccinated.”

Dennis Bourdette, M.D., discusses the need for greater communication between physicians and insurers.

Mark Slifka, Ph.D., discusses how mRNA technology has advanced vaccine development and helped address the pandemic.